首页> 美国卫生研究院文献>Scientific Reports >Self-assembled IR780-loaded transferrin nanoparticles as an imaging targeting and PDT/PTT agent for cancer therapy
【2h】

Self-assembled IR780-loaded transferrin nanoparticles as an imaging targeting and PDT/PTT agent for cancer therapy

机译:自组装的IR780载运铁蛋白纳米颗粒作为成像靶向和PDT / PTT试剂用于癌症治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Combination of photothermal and photodynamic therapy (PTT/PDT) offer unique advantages over PDT alone. However, to achieve synergetic PDT/PTT effect, one generally needs two lasers with different wavelengths. Near-infrared dye IR-780 could be used as photosensitizer both for PTT and PDT, but its lipophilicity limits its practical use and in vivo efficiency. Herein, a simple multifunctional IR780-loaded nanoplatform based on transferrin was developed for targeted imaging and phototherapy of cancer compatible with a single-NIR-laser irradiation. The self-assembled transferrin-IR780 nanoparticles (Tf-IR780 NPs) exhibited narrow size distribution, good photo-stability, and encouraging photothermal performance with enhanced generation of ROS under laser irradiation. Following intravenous injection, Tf-IR780 NPs had a high tumor-to-background ratio in CT26 tumor-bearing mice. Treatment with Tf-IR780 NPs resulted in significant tumor suppression. Overall, the Tf-IR780 NPs show notable targeting and theranostic potential in cancer therapy.
机译:与单独的PDT相比,光热疗法和光动力疗法(PTT / PDT)的组合具有独特的优势。然而,为了达到协同的PDT / PTT效果,通常需要两个波长不同的激光器。近红外染料IR-780可以用作PTT和PDT的光敏剂,但其亲脂性限制了其实际应用和体内效率。在本文中,开发了一种基于转铁蛋白的简单,多功能,装载IR780的纳米平台,用于与单NIR激光照射兼容的癌症的靶向成像和光疗。自组装的转铁蛋白-IR780纳米颗粒(Tf-IR780 NPs)具有窄的尺寸分布,良好的光稳定性和令人鼓舞的光热性能,并在激光照射下增强了ROS的生成。静脉注射后,Tf-IR780 NP在携带CT26肿瘤的小鼠中具有很高的肿瘤与背景比率。用Tf-IR780 NPs治疗可显着抑制肿瘤。总体而言,Tf-IR780 NP在癌症治疗中显示出显着的靶向性和治疗诊断潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号